T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ALXN
176
DELISTED
Alexion Pharmaceuticals
ALXN
| $767M | 0.12% |
8,542,685
-3,563,213
| -29% | -$350M |
|
|
ZEN
177
DELISTED
ZENDESK INC
ZEN
| $767M | 0.12% |
11,981,817
-1,348,722
| -10% | -$105M |
|
178
TotalEnergies
TTE
$194B
| $767M | 0.12% |
20,594,691
+6,177,964
| +43% | +$278M |
|
179
Weyerhaeuser
WY
$17.8B
| $763M | 0.12% |
44,987,579
+5,178,495
| +13% | +$136M |
|
180
Intel
INTC
$509B
| $757M | 0.12% |
13,989,998
+5,164,527
| +59% | +$306M |
|
181
Teledyne Technologies
TDY
$31.8B
| $757M | 0.12% |
2,546,381
+1,357,110
| +114% | +$466M |
|
182
Motorola Solutions
MSI
$77.7B
| $755M | 0.12% |
5,677,352
+151,267
| +3% | +$25.4M |
|
183
IDEX
IEX
$17.7B
| $749M | 0.12% |
5,425,588
+67,143
| +1% | +$10.5M |
|
184
Old Dominion Freight Line
ODFL
$44.1B
| $749M | 0.12% |
11,414,290
+3,109,045
| +37% | +$207M |
|
185
Bright Horizons
BFAM
$3.76B
| $747M | 0.12% |
7,328,319
+442,369
| +6% | +$65M |
|
186
Chevron
CVX
$386B
| $747M | 0.12% |
10,309,210
+4,372,353
| +74% | +$432M |
|
187
Accenture
ACN
$110B
| $742M | 0.12% |
4,545,733
+206,816
| +5% | +$39.8M |
|
188
Wynn Resorts
WYNN
$10.6B
| $739M | 0.12% |
12,282,160
-738,873
| -6% | -$82.8M |
|
189
Crown Castle
CCI
$31.5B
| $725M | 0.11% |
5,023,245
+240,983
| +5% | +$35.9M |
|
190
Norfolk Southern
NSC
$75.3B
| $725M | 0.11% |
4,962,436
+866,732
| +21% | +$160M |
|
191
Mondelez International
MDLZ
$79.4B
| $718M | 0.11% |
14,342,305
+1,850,347
| +15% | +$100M |
|
192
Carvana
CVNA
$79.7B
| $716M | 0.11% |
65,010,240
+54,435,810
| +515% | +$842M |
|
193
Deere & Co
DE
$167B
| $716M | 0.11% |
5,182,793
+1,378,580
| +36% | +$218M |
|
194
Cboe Global Markets
CBOE
$30.4B
| $712M | 0.11% |
7,981,329
-4,047,291
| -34% | -$453M |
|
|
PXD
195
DELISTED
Pioneer Natural Resource Co.
PXD
| $712M | 0.11% |
10,152,981
-2,204,855
| -18% | -$262M |
|
196
Okta
OKTA
$25.6B
| $707M | 0.11% |
5,779,639
-1,026,364
| -15% | -$129M |
|
197
DuPont de Nemours
DD
$19.5B
| $701M | 0.11% |
16,379,927
+5,214,034
| +47% | +$319M |
|
198
International Paper
IP
$21.8B
| $699M | 0.11% |
23,720,222
+4,416,885
| +23% | +$164M |
|
199
StoneCo
STNE
$2.43B
| $695M | 0.11% |
31,912,264
-926,565
| -3% | -$35.3M |
|
200
Alnylam Pharmaceuticals
ALNY
$30B
| $684M | 0.11% |
6,287,760
+936,668
| +18% | +$108M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.